DRUG · Unmapped registry intervention
DA-1229_01(A), Sugamet SR Tab 5/1000mg®
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State
NCT03939143
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Sugamet SR Tab 5/1000mg®, DA-1229_01(A)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Type2 Diabetesunresolved
Interventions
Sponsors & collaborators
Dong-A ST Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03939143 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.